Invention Grant
- Patent Title: Antibody buffering of a ligand in vivo
- Patent Title (中): 体内配体的抗体缓冲
-
Application No.: US11226055Application Date: 2005-09-13
-
Publication No.: US09173958B2Publication Date: 2015-11-03
- Inventor: Jefferson Foote , Carol E. O'Hear
- Applicant: Jefferson Foote , Carol E. O'Hear
- Applicant Address: US WA Seattle
- Assignee: Arrowsmith Technologies Corporation
- Current Assignee: Arrowsmith Technologies Corporation
- Current Assignee Address: US WA Seattle
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- Main IPC: C07K16/44
- IPC: C07K16/44 ; A61K49/16 ; A61K47/48 ; A61K39/395 ; A61K45/06 ; C07K16/18 ; C07K16/40 ; A61K39/00

Abstract:
Compositions and methods are provided in embodiments directed to maintaining a desired concentration range of one or more drugs in a subject, and in particular embodiments to maintaining a desired drug concentration in a body compartment in a subject, based on the surprising discovery that antibodies persist in solution in body compartments such that antibody-antigen equilibrium principles can counteract drug clearance mechanisms. One or more antibodies are selected that have a dissociation constant KD that is similar to the desired drug concentration, wherein KD is independent of the affinity of the drug for a specific drug target (receptor) in the subject.
Public/Granted literature
- US20060062778A1 Antibody buffering of a ligand in vivo Public/Granted day:2006-03-23
Information query